Christine Gispen

Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden — Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials

Luca Pani, Spiros Vamvakas, Eric Abadie, 2011, European Neuropsychopharmacology.